UPDATE 3-GSK slides after buying cancer firm Tesaro for hefty $5.1 bln


GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. FILE PHOTO: The GlaxoSmithKline logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018.



from Biotech News